Introduction Diabetes Mellitus Types I and II affect millions of people. While diabetes can be managed with a mixture of lifestyle changes, medication, and insulin, the current treatment is cumbersome and inconvenient, meaning many patients are non-compliant. The consequences of untreated diagnoses are serious, but there are currently no convenient

When most people think of diabetes, they think of Diabetes Mellitus. Millions of people are affected by Diabetes Mellitus (DM). DM affects multiple organ systems, and, untreated, has many consequences. The focus of the medical community has been both prevention and treatment. New, innovative, treatment options are in the development

Diabetes Mellitus (DM) is a disease that affects millions of people. Both types of diabetes, Type I and Type II, cause elevated levels of blood sugar. However, the causes of both are different, and therefore the treatments are different. Despite multiple treatment options, DM can be difficult to treat. There

With proper care and treatment, diabetes is manageable, but no cure is yet available for this disease. Transforming stem cells into insulin-secreting cells may be the answer to finally curing diabetes. Note: Despite all advances in stem cells research and the application of these therapies in many countries all over

Diabetes is a global health problem affecting an estimated 346 million people worldwide and a leading cause of death. Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin, or when the body cannot effectively use the insulin it produces. Type 2 diabetes

Diabetes Mellitus affects 346 million people and is one of the leading causes of death worldwide. Serious complications caused by diabetes include:

Diabetes is sometimes referred to as the “silent killer” because it can progress slowly and without warning. It is a common condition worldwide, but because the symptoms may present slowly or not at all, many people are not aware they have it. Once they are diagnosed, patients may still not

Scientists found that people considered vitamin D deficient were at five times greater risk of developing type II diabetes. Diabetes mellitus type 2 is a serious, chronic, metabolic disorder characterized by high blood sugar, insulin resistance, and lack of insulin. Serious complications caused by type 2 diabetes include, organ damage, heart

Type II diabetes is the most common form of diabetes, affecting more than 400 million people worldwide. Type II diabetes is a chronic disease that affects how glucose is metabolized; initially a person with type 2 diabetes will still produce insulin, but his or her cells no longer use the insulin

Recent studies show; (1) Onset of type 1 diabetes is equally likely to occur after age 30 as prior to age 30 and, (2) the risk of developing one or more additional autoimmune diseases increases with age of onset of type 1 diabetes. The results of these studies are significant

Each year diabetes kills approximately 80,000 people in the United States and in 2017, the American Diabetes Association estimated that 7.2 million Americans have diabetes but don’t know it. Diabetes is one of the diseases called a “silent killer” because it can develop without obvious signs so it is important

Approximately 425 million people worldwide suffer from diabetes, a major cause of blindness, kidney failure, heart attacks, stroke and lower limb amputation. According to the World Health Organization, in 2015, an estimated 1.6 million deaths were directly caused by diabetes. Diabetes is a challenging disease to treat but stem cell therapy

Type 1 Diabetes is a common life-long condition and globally the number of children diagnosed with type 1 diabetes is increasing. For patients diagnosed with type 1 diabetes it means living with daily insulin injections and  a high risk of long-term health problems as a result.

What is diabetes mellitus and how can stem cells be used? The global incidence of diabetes mellitus has increased dramatically over the past few years and continues to rise. The quest for curative therapies, that normalize blood sugar levels and provide independence from exogenous insulin therapies, impacts patients with type